world asthma foundation logo

Tag: drug

  • Cysteinyl Leukotrienes Pathway Genes, Atopic Asthma and Drug Response: From Population Isolates to Large Genome-Wide Association Studies.

    Related Articles Cysteinyl Leukotrienes Pathway Genes, Atopic Asthma and Drug Response: From Population Isolates to Large Genome-Wide Association Studies. Front Pharmacol. 2016;7:299 Authors: Thompson MD, Capra V, Clunes MT, Rovati GE, Stankova J, Maj MC, Duffy DL Abstract Genetic variants associated with asthma pathogenesis and altered response to drug therapy are discussed. Many studies implicate […]

  • Drug win for asthma sufferers – The Advertiser

    Drug win for asthma sufferersThe AdvertiserThe Coalition will spend $5.4 million to make Omalizumab — an injectable medication used to treat severe asthma not controlled by corticosteroid inhalers — available to hundreds of patients across Australia. The drug is used to treat people who … View full post on asthma – Google News

  • Break for allergic asthma sufferers as ‘lifesaving’ drug subsidised – Herald Sun

    Herald Sun Break for allergic asthma sufferers as 'lifesaving' drug subsidisedHerald SunThe Coalition will spend $5.4 million to make Omalizumab — an injectable medication used to treat severe asthma not controlled by corticosteroid inhalers — available to hundreds of patients across Australia. The drug is used to treat people who …and more » View full post […]

  • Brentford star Alan Judge reprimanded after being found with too much asthma-treating drug Salbutamol in his system – getwestlondon

    getwestlondon Brentford star Alan Judge reprimanded after being found with too much asthma-treating drug Salbutamol in his systemgetwestlondonThe Irishman, who has suffered from exercise-induced asthma since he was a child, was deemed to have too much Salbutamol, a common drug used for treating the condition via an inhaler, in his system. Judge has permission by […]

  • AstraZeneca’s Severe Asthma Drug Positive in Phase III – Zacks.com

    Wall Street Journal AstraZeneca's Severe Asthma Drug Positive in Phase IIIZacks.comThese randomized, double-blind, parallel-group, placebo-controlled studies evaluated the safety and efficacy of benralizumab as an add-on therapy in the treatment of severe uncontrolled asthma with eosinophilic inflammation in patients aged 12 years …AstraZeneca's Asthma Drug Shows Positive ResultsWall Street JournalAstraZeneca set to go head to […]

  • AstraZeneca’s Asthma Drug Shows Positive Results – Wall Street Journal

    Wall Street Journal AstraZeneca's Asthma Drug Shows Positive ResultsWall Street JournalBing Yao, head of respiratory medicine at AstraZeneca's MedImmune unit, said benralizumab acted directly on the cells that are thought to cause attacks in patients with severe asthma. He said the Glaxo and Teva drugs, by contrast, act indirectly by …AstraZeneca set to go head […]

  • AstraZeneca Asthma Drug Shows Positive Results – Wall Street Journal

    Reuters AstraZeneca Asthma Drug Shows Positive ResultsWall Street JournalBing Yao, head of respiratory medicine at the company's MedImmune unit, said benralizumab acted directly on the cells that are thought to cause attacks in severe asthma patients. He said the Glaxo and Teva drugs, by contrast, act indirectly by …AstraZeneca asthma drug hits goal, to enter […]

  • AstraZeneca asthma drug hits goal, to enter competitive market – Reuters

    Reuters AstraZeneca asthma drug hits goal, to enter competitive marketReutersL) drive to rebuild its portfolio of new medicines received a boost with positive results for an experimental biotech drug for severe asthma that the company previously flagged as a potential $2 billion-a-year seller. Benralizumab, which is likely to …AstraZeneca: Asthma drug trial results positiveMarketWatchAstrazeneca Reports […]

  • AstraZeneca boosted by good results for biotech asthma drug – Reuters

    Reuters AstraZeneca boosted by good results for biotech asthma drugReutersLONDON AstraZeneca's (AZN.L) drive to rebuild its portfolio of new medicines received a boost on Tuesday with positive results for a biotech drug for severe asthma that the company has previously flagged as a potential $2 billion-a-year product.AstraZeneca: Asthma drug trial results positiveMarketWatchAstrazeneca Reports Results On […]

  • AstraZeneca: Asthma drug trial results positive – MarketWatch

    Reuters UK AstraZeneca: Asthma drug trial results positiveMarketWatchLONDON–AstraZeneca PLC (AZN.LN) said Tuesday its potential new medicine benralizumab showed positive results in a Phase III trial for asthma treatment. The treatment "was well tolerated and achieved the primary endpoint in two pivotal Phase III …AstraZeneca boosted by good results for biotech asthma drugReuters UKAstrazeneca Reports Results On […]